Joshua Z Rosenthal

Summary

Publications

  1. doi request reprint Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial
    Joshua Z Rosenthal
    Capital Clinical Research Associates, Rockville, MD 20852, USA
    J Clin Psychiatry 74:158-66. 2013

Collaborators

Detail Information

Publications1

  1. doi request reprint Efficacy and safety of desvenlafaxine 50 mg/d for prevention of relapse in major depressive disorder:a randomized controlled trial
    Joshua Z Rosenthal
    Capital Clinical Research Associates, Rockville, MD 20852, USA
    J Clin Psychiatry 74:158-66. 2013
    ..To evaluate the long-term (11-month) efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) at the recommended 50-mg/d dose in preventing relapse in patients with major depressive disorder (MDD)...